Exide Industries Ltd

Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.

Exide Industries Ltd trades at ₹413, in a confirmed uptrend and 13 weeks into that stage. That is +4.6% against its own 200-day average. It sits at 60% of a 52-week range of ₹297 to ₹490. On relative strength it has been ahead of the NIFTY 500 on a trailing-13-week view for 27 straight weeks.

Today the stock is in a confirmed uptrend — week 13 of stage 2, confirmed. At ₹413 it trades +4.6% versus its 200-day average and sits at 60% of its 52-week range (₹297–₹490).

Against the market, two honest reads. Cumulative: over the last 10.5 years the stock moved +213% while the NIFTY 500 moved +267% — behind the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 27 straight weeks — the ribbon below is that same metric, week by week.

What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.

Story check

Exide Industries Ltd's story is not scored yet against the markers our research file set on 22 August 2026. Where it sits in its own cycle: EARLY_EXPANSION. Our fortnightly research layers last read it on 22 August 2026.

Our read, 22 August 2026. Exide combines a cash-generative lead-acid core self-funding its ₹6,000+ Cr lithium giga-factory with an elevated 41.6x PE multiple that requires prompt EV cell commercialization to justify valuation.

From the numbers. Exide sits in an early operating cycle expansion stage with TTM revenue growing 7.6% and operating profit reaching ₹621 Cr in Q1 FY27. However, the valuation multiple has re-rated to 41.6x PE (91st percentile of 10-year…

From the price. Price stage 2, week 13 — above its 200-day line, relative strength falling.

From the research. Exide combines a cash-generative lead-acid core self-funding its ₹6,000+ Cr lithium giga-factory with an elevated 41.6x PE multiple that requires prompt EV cell commercialization to justify valuation.

🚨 Where they disagree. Exide sits in an early operating cycle expansion stage with TTM revenue growing 7.6% and operating profit reaching ₹621 Cr in Q1 FY27. However, the valuation multiple has re-rated to 41.6x PE (91st percentile of 10-year history) against a 10-year median of 22.9x. Because current operating margins of 11.2% are at mid-cycle levels (55th percentile) rather than cyclically depressed, normalizing earnings yields a PE of 36.6x (80th percentile). This confirms the deterministic classification of RE_RATED_EXPENSIVE, where multiple expansion has run ahead of reported earnings in anticipation of lithium commercialization.

What is proven. Exide combines a cash-generative lead-acid core self-funding its ₹6,000+ Cr lithium giga-factory with an elevated 41.6x PE multiple that requires prompt EV cell commercialization to justify valuation.

What is not proven yet. Rejection of EESL cylindrical or prismatic cell samples by lead two-wheeler OEMs, prolonged cell manufacturing yields below 70%, or a structural contraction in core lead-acid annual operating cash flow below ₹1,200 Cr.

🚨 What would change our mind. Rejection of EESL cylindrical or prismatic cell samples by lead two-wheeler OEMs, prolonged cell manufacturing yields below 70%, or a structural contraction in core lead-acid annual operating cash flow below ₹1,200 Cr.

🚨 Layer 1 read, 22 August 2026 — DROP. Top-decile multiple for a lithium plant that has not sold one cell, on a business compounding 3% a year. Exide's battery business is a solid cash generator — 2,413 crores of operating cash in FY26 against 860 crores of profit — but it is not a growth business: profit went from 700 to 937 crores over ten years and the operating margin has been flat at 9-11% for all twelve quarters. The shares nonetheless trade at 41.6 times, the 91st percentile of their own decade and nearly double the 22.9 median, and the timeline concedes normalising margins only takes that to 36.6 times. That premium is entirely for the 6 GWh lithium plant, which has swallowed 4,802 crores of equity, has recognised no commercial revenue, already missed its production start (GP1), and sits under management that withdrew…

What would change Layer 1’s mind. Consuming the lithium driver's own kill-switch and sharpening it to this layer: the flip is EESL recognising its first 50 crores of commercial cell revenue by Q3 FY27 (the document's own M2 milestone) with at least one of the three two-wheeler makers converting homologation into a binding purchase order. That turns the option into an earnings line and I upgrade to P1 despite the multiple. The reverse: if a lead two-wheeler maker rejects the cell samples or production yields stay below 70% past…

The test written in advance. Rejection of EESL cylindrical or prismatic cell samples by lead two-wheeler OEMs, prolonged cell manufacturing yields below 70%, or a structural contraction in core lead-acid annual operating cash flow below ₹1,200 Cr. — the thesis as written as stated by the next result.

The test written in advance. Lithium Cell Yield, Ramp, and Technology Transition Delays — Lithium Cell Yield, Ramp, and Technology Transition Delays First commercial revenue recognition from EESL by Q3 FY27 and disclosure of production yield milestones exceeding 75%. by the next result.

The test written in advance. Re-Rated Valuation Multiples Pricing in Flawless Execution — Re-Rated Valuation Multiples Pricing in Flawless Execution TTM EPS growth falling below 15% YoY while the trailing PE remains above 40x. by the next result.

🚨 What the surface reading misses. The surface reading is: Trailing PE at 41.6x (91st percentile of 10-year history) indicates an expensive valuation, while ROE at 5.97% reflects depressed return ratios. The research reads it further: The valuation multiple re-rated ahead of earnings because the market is capitalizing future lithium-ion cell manufacturing cash flows (6 GWh Phase 1 Bengaluru plant) rather than pricing trough lead-acid earnings; operating margins are at mid-cycle levels (11.2%, 55th percentile), so the multiple is genuinely elevated rather than optically distorted by depressed operating margins.

🚨 What the surface reading misses. The surface reading is: Q1 FY27 net profit of ₹351 Cr indicates sharp earnings expansion. The research reads it further: Operating leverage from peak seasonal inverter demand and automotive replacement volume (+21% 4W OEM, +20% 2W OEM) drove operating profit to ₹621 Cr, with no exceptional one-off gains recorded in the ledger.

Lever 12 · New product launch — BUILDING. Homologation with three major two-wheeler EV manufacturers representing 80-85% market share secures initial cell volume off-take. What proves it keeps working: Automotive OEM Homologation Pipeline (The Homologation Moat). It stops working if Leading two-wheeler OEMs select alternative domestic cell suppliers or backward integrate into proprietary pack production.

Lever 2 · Value-added mix — BUILDING. Lead-acid replacement market (70% of auto mix) delivers consistent double-digit volume growth with multi-tranche price pass-through. What proves it keeps working: Aftermarket Pricing Power and Channel Dominance. It stops working if Unorganized sector competition or price resistance prevents passing on sudden commodity spikes in lead and sulfuric acid.

Sources: our stock research file (22 August 2026) · quarterly results through Jun 26 · the company’s own earnings calls. The story check is re-scored every results season; the record below never changes.

Revenue Revenue is the top line: everything the company billed its customers in the period.

Exide Industries Ltd reported ₹5,528 Cr of revenue in the Jun 26 quarter, +17.7% year on year. That is the 3rd straight quarter of year-on-year growth. Over 10 years it has compounded at 6.6% a year. The last full year, FY26, came in at ₹17,995 Cr. The last four reported quarters add to ₹18,829 Cr.

Why this happened. Exide has entered formal qualification with top two-wheeler EV manufacturers and secured 100% lead-acid supply positions on passenger vehicle platforms including Tata Sierra and Kia Seltos. Converting these sample validations into commercial purchase orders locks in long-term supply relationships.

FY26 revenue came in at ₹17,995 Cr (+4.4% on the year), capping 10 years at 6.6% compound. The latest quarter (Jun 26) printed ₹5,528 Cr, +17.7% year on year — the 3rd consecutive quarter of year-over-year growth.

Pace check: the last four quarters averaged +7.4% growth against the decade's 6.6% — the current year is running in line with its own long-run rate.

Acceleration check: trailing-twelve-month revenue grew +7.6% over the last 4 quarters against +5.4%/yr over the last 8 — stabilising; TTM profit +9.7% vs +3.2%/yr — accelerating.

FY26-Q4. revenue ₹4,735 Cr and profit ₹217 Cr as reported.

FY27-Q1. revenue ₹5,528 Cr and profit ₹351 Cr as reported.

Why-sources: our stock research file (22 August 2026) and the company’s own results for those quarters.

Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.

Exide Industries Ltd's operating margin is 11.0% in the Jun 26 quarter, +0.0 percentage points against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged 10.0% to 13.0%. The current quarter sits inside that band.

The latest quarter's operating margin is 11.0%, +0.0 pp against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged 10.0%–13.0%.

🚨 Why the margin moved: operating margin went −0.2 pp year on year while gross margin went −1.6 pp — the loss came mostly from the gross line: input costs and pricing.

FY26-Q4. revenue ₹4,735 Cr and profit ₹217 Cr as reported.

FY27-Q1. revenue ₹5,528 Cr and profit ₹351 Cr as reported.

Why-sources: our stock research file (22 August 2026) and the company’s own results for those quarters.

Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.

Exide Industries Ltd earned ₹351 Cr of net profit in the Jun 26 quarter, +27.6% year on year. It is the 3rd consecutive quarter of growth. Full-year FY26 profit was ₹860 Cr. The 10-year compound rate is 2.1%. That is 6.3% of the quarter's revenue. The same quarter a year earlier earned ₹275 Cr.

Jun 26 profit was ₹351 Cr, +27.6% year on year — the 3rd consecutive quarter of growth. On the full year, FY26 printed ₹860 Cr (+7.5%), and the 10-year compound rate is 2.1%.

Why profit moved: revenue contributed +17.7% and the margin +0.0 pp — the quarter was revenue-led, with the margin roughly flat.

Pace comparison, last four quarters: profit +10.3% vs revenue +7.4%. Profit and revenue are moving roughly in step.

FY26-Q4. revenue ₹4,735 Cr and profit ₹217 Cr as reported.

FY27-Q1. revenue ₹5,528 Cr and profit ₹351 Cr as reported.

Why-sources: our stock research file (22 August 2026) and the company’s own results for those quarters.

Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.

Over the last 3 fiscal years 205% of Exide Industries Ltd's reported profit arrived as operating cash — the cash follows the profit. In FY26 that was ₹2,413 Cr of operating cash against ₹860 Cr of profit. After ₹1,215 Cr of capital spending, ₹1,198 Cr was left as free cash.

FY26: operating cash of ₹2,413 Cr against reported profit of ₹860 Cr, leaving free cash of ₹1,198 Cr after ₹1,215 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 205% of profit.

Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.

Why conversion sits at 205%: the cash cycle held roughly steady between FY21 and FY26 — so conversion tracks profitability rather than the cycle.

Router verdict: the bigger cash user is investment — capital spending ran 3.3× depreciation over three years, so the next section's job is to check what that build-out is buying.

Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).

Exide Industries Ltd's cash conversion cycle runs 42 days in FY26, down from 52 days in FY21. Capital spending ran ₹5,728 Cr over the last 3 years. At FY26 sales of ₹17,995 Cr each day of that cycle holds about ₹49.3 Cr, so roughly ₹2,071 Cr sits inside the business at any moment.

Why this happened. With ₹4,802 Cr cumulative equity deployed into Exide Energy Solutions, equipment installation is operational and customer sampling has commenced for NMC cylindrical and LFP prismatic lines. Management targets initial commercial revenue in FY27 by substituting imported cells across electric two-wheelers, three-wheelers, and stationary storage.

FY26: debtors at 32 days, inventory at 120 days — roughly 3.9 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 42 days, tighter than FY21's 52.

The full loop: cash goes out to suppliers and production on day 0; stock waits 120 days to sell; customers pay about 32 days after that; and suppliers themselves are paid at 110 days — netting out to the 42-day cycle.

In money terms: at FY26 sales of ₹17,995 Cr, each day of the cycle holds about ₹49.3 Cr — so the 42-day loop keeps roughly ₹2,071 Cr sitting inside the business at any moment.

On the investment side: capital spending of ₹5,728 Cr over the last 3 fiscal years against ₹1,731 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹4,198 Cr (FY26) — capacity paid for but not yet earning.

The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.

Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.

Exide Industries Ltd earns a ROCE of 9% in FY26. Return on invested capital clears the cost of that capital by −5.4 percentage points, so growth here is not yet paying for the capital it uses. The wiring behind it is 4.8% net margin on 0.85× asset turns.

FY26 ROCE is 9%.

🚨 Why the return is what it is — the wiring (FY26): 4.8% net margin × 0.85× asset turns × 1.53× balance-sheet leverage ≈ 6.2% on equity. Margin does its share; leverage is modest — this is an earned return, not a borrowed one.

The capstone test — ROIC − WACC: 6.6% − 12.0% = a −5.4 pp spread. The 12.0% is a standing assumption for the cost of capital in India, not a per-stock estimate — read the sign and the size of the spread, not the decimals. Negative — growth at these returns destroys value until the returns recover.

Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.

Exide Industries Ltd carries total debt of ₹1,575 Cr against shareholder equity of ₹13,931 Cr as of Mar 26, a debt-to-equity of 0.11 — effectively unlevered. On the annual view that ratio went from 0.05 in FY22 to 0.11 in FY26. The returns elsewhere on this page are therefore earned rather than borrowed.

Mar 26: total debt of ₹1,575 Cr against shareholder equity of ₹13,931 Cr — a debt-to-equity of 0.11. On the annual view, debt-to-equity went from 0.05 (FY22) to 0.11 (FY26). The returns on this page are earned, not borrowed.

Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.

Foreign institutions cut 3.1 points of Exide Industries Ltd over 8 quarters, the biggest move on the register. That takes foreign institutions to 10.6% of the company. Domestic institutions moved +1.4 points over the same window, to 19.3%. The register is read on the four disclosed classes only; nothing is inferred between filings.

The register over the last two years — Foreign institutions: −3.1 points over 8 quarters to 10.6%; Domestic institutions: +1.4 points over 8 quarters to 19.3%; Promoters: +0.0 points over 8 quarters to 46.0%.

🚨 Why the register moved: foreign institutions drove it (−3.1 points), absorbed on the other side by domestic institutions (+1.4 points) — distribution into the market’s bid.

Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.

Exide Industries Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.

The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.

Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.

Exide Industries Ltd trades at 37.4× P/E, at the pricey end of its own range (80th percentile). Its long-run median P/E is 23.8×, measured across 10.5 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.

Today's P/E of 37.4× is at the pricey end of its own range (80th percentile), against a long-run median of 23.8× measured over 10.5 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.

Why the multiple sits where it does: over the past year annual EPS moved +7.5% against a −1.4% price move — earnings outran the price, pushing the multiple DOWN its own range.

The price move, decomposed: over 5y, of the +17.8%/yr price move, ~+4.0%/yr came from earnings growth and ~+13.8 pp from the multiple (expanding); over 10y, of the +8.0%/yr price move, ~+2.9%/yr came from earnings growth and ~+5.1 pp from the multiple (expanding). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.

Put together: the multiple is full against its own past, so the story rests on the earnings line underneath it, not the multiple.

Stage: Mixed Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).

Exide Industries Ltd reads as mixed on its fundamental arc. Mixed — no clean majority across the growth curves, ROCE holding at 8.9% — the per-curve reads carry the story. The read is built from 12 quarters across 4 curves, on full evidence.

Why it matters: when the curves disagree, the per-curve reads above matter more than any single verdict.

4-Factor Sector Score

38.9/100 — rank 1 of 3 in Auto Ancillaries - Batteries · 97% evidence confidence

Exide Industries Ltd scores 38.9 out of 100 against the 3 companies it is compared with in Auto Ancillaries - Batteries, ranking 1. Price leads the evidence: RS versus the benchmark is 11.2%, but earnings trajectory is weak. Wait for revenue and profit confirmation.

The four contributions add to the total exactly: 16 + 6.1 + 2.1 + 14.7 = 38.9. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.

What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.

Said versus delivered

What Exide Industries Ltd's management promised, set against what actually arrived — 4 tracked promises on the record. Read straight from the company’s own earnings calls. A promise that slipped stays on this page after it is met.

FY27 Core Growth Outlook Withdrawn · 3 August 2026. In May 2026, management said the core business had the potential to deliver at least high-single-digit to early-double-digit growth in FY27. In Aug 2026, despite reporting 17.6% Q1 FY27 revenue growth, management declined to provide full-year guidance, representing a meaningful retreat from the prior directional outlook; although base effects and seasonality were cited, management did not explicitly reconcile this withdrawal with the earlier growth expectation.

Technology Partner Named Differently - SVOLT vs. Gotion · 6 May 2026. In the Nov 2025 call, management explicitly named SVOLT as the "principal partner" for the lithium-ion cell manufacturing project, citing it as the source of raw material scale and reliability. In the May 2026 call, the MD and CEO of Exide Energy Solutions cited Gotion - a completely different Chinese battery manufacturer - as the provider of technology support, with no mention of SVOLT. No explanation was provided for this discrepancy, which is material given the approximately 5,000 crore total equity investment in the project.

Export Recovery Commitment Not Delivered · 6 May 2026. In the Nov 2025 call, management made a confident and specific commitment that export revenues would begin recovering from Q4 FY26 onwards, explicitly citing completed trials and new geographies and portfolio additions as the basis for that confidence. The May 2026 call reveals exports were still in sharp decline through Q4 FY26 and management now guides for continued weakness through H1 FY27 - a delay of roughly a full year from the prior commitment - with no explanation beyond the same broad geopolitical environment that was already acknowledged in November 2025.

🚨 Lithium-Ion Production Start Timeline Missed · 6 May 2026. In the Nov 2025 call, management committed to starting production at Exide Energy towards the end of FY26, characterizing installation and commissioning as nearing completion. By May 2026 - already two months into Q1 FY27 - customer sample delivery for the cylindrical line was only just commencing that month and the prismatic line was still initiating trials. This represents at least a one-quarter slip for the primary line and a longer delay for the prismatic line from the end-of-FY26 commitment, with no clear explanation offered beyond standard process validation language.

Every quote above is taken word for word from the company’s own earnings calls.

Frequently asked questions